| Financial Year |
March 31 2023 |
| Monetary Funds |
915,134,777.70 |
| Held-for-trading Financial Assets |
669,470,180.55 |
| Notes Receivable |
3,784,656.05 |
| Accounts Receivable |
177,439,155.89 |
| Advances to Suppliers |
68,486,672.12 |
| Other Receivables |
1,428,357.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
501,499,625.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,073,726.44 |
| Total Current Assets |
2,435,177,285.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
41,977,352.82 |
| Fixed Assetes |
364,388,141.04 |
| Under-construction Projects |
86,445,264.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
126,959,120.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,808,311.84 |
| Deferred Income Tax Assets |
43,998,864.36 |
| Other Non-Current Assets |
84,944,974.91 |
| Sub-Total of Non-Current Assets |
888,003,813.91 |
| Total Assets |
3,323,181,099.13 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
220,105,929.39 |
| Accounts Payable |
73,877,539.53 |
| Accounts Received In Advance |
596,194.16 |
| Employee Compensation Payable |
26,395,516.60 |
| Taxes Payable |
40,593,948.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,155,063.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,957,499.48 |
| Other Current Liabilities |
5,655,414.55 |
| Sub-Total of Current Liabilities |
430,861,826.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,833,701.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,132,028.53 |
| Total Liabilities |
442,993,855.01 |
| Paid-In Capital(Or Share Stock) |
150,000,000.00 |
| Capital Surplus |
1,667,880,449.19 |
| Surplus Reserve |
75,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
966,744,605.47 |
| Minority Stockholder's Interest |
19,790,764.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,860,396,479.61 |
| Owner's Equity（Stockholder's Equity） |
2,880,187,244.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,323,181,099.13 |
